

CLASSIFICATION: ORGAN-SPECIFIC PEPTIDE
ACTIVE SUBSTANCE: PANCRAGEN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 20 MG)
ACTIVE HALF-LIFE: APPROX. 6–8 HOURS
DOSAGE: 20–40 MG/WEEK (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
Pancragen is an organ-specific peptide complex designed to support pancreatic health, insulin signaling, and beta-cell activity. Derived from natural cytomedin peptides targeting the pancreas, Pancragen may regulate gene expression, enhance tissue repair, and support glucose metabolism in research settings. Peptide Hubs provides Pancragen in a 20 mg lyophilized format suitable for advanced metabolic and endocrine research.
Pancragen's mechanism focuses on restoring pancreatic tissue function at the molecular level. The short peptides in Pancragen bind to nuclear structures and modulate gene expression, potentially enhancing insulin production and protecting beta cells. This mechanism aligns with cytogenetic peptide research as discussed in this NIH article on peptide bioregulators.
Pancragen is frequently combined with Semaglutide or MOTS-c in research focused on metabolic and glycemic regulation. For oxidative stress and mitochondrial protection, Humanin is a common stack. DNA integrity and cellular repair models may also include FOX04-DRI or L-Glutathione.
Pancragen is not approved by the FDA and is intended for research purposes only. No androgenic, estrogenic, or hepatotoxic effects have been reported in preclinical data. Proper storage and handling protocols should be followed as per institutional guidelines.
Pancragen is studied for its role in pancreatic tissue repair, insulin signaling, and beta-cell function support in models of metabolic dysfunction.
Research suggests Pancragen may help support insulin gene expression and pancreatic beta-cell recovery, though it is not a replacement for insulin itself.
Yes. It is often stacked with compounds like Semaglutide or MOTS-c in studies related to glucose homeostasis and insulin sensitivity.
No. Pancragen is not FDA-approved. It is intended for laboratory use only and is not sold for human or veterinary administration.
Please log in to write PANCRAGEN 20 MG review.
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: 200–300 MCG 2–3 TIMES DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–2.5 MG TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE COMBINATION
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL TOTAL)
ACTIVE HALF-LIFE: ~ 2–6 HOURS
DOSAGE: 500–1000 MCG DAILY EACH
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MELANOCORTIN PEPTIDE ANALOG
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 33 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: POSSIBLE
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 1–2 MG DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: SERMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 11–12 MINUTES
DOSAGE: 100–300 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SEMAX
FORM: 2 ML VIAL (30 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–5 HOURS
DOSAGE: 200–500 MCG ONCE OR TWICE DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS